» Articles » PMID: 26709961

Modeling the Slow CD4+ T Cell Decline in HIV-Infected Individuals

Overview
Specialty Biology
Date 2015 Dec 29
PMID 26709961
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

The progressive loss of CD4+ T cell population is the hallmark of HIV-1 infection but the mechanism underlying the slow T cell decline remains unclear. Some recent studies suggested that pyroptosis, a form of programmed cell death triggered during abortive HIV infection, is associated with the release of inflammatory cytokines, which can attract more CD4+ T cells to be infected. In this paper, we developed mathematical models to study whether this mechanism can explain the time scale of CD4+ T cell decline during HIV infection. Simulations of the models showed that cytokine induced T cell movement can explain the very slow decline of CD4+ T cells within untreated patients. The long-term CD4+ T cell dynamics predicted by the models were shown to be consistent with available data from patients in Rio de Janeiro, Brazil. Highly active antiretroviral therapy has the potential to restore the CD4+ T cell population but CD4+ response depends on the effectiveness of the therapy, when the therapy is initiated, and whether there are drug sanctuary sites. The model also showed that chronic inflammation induced by pyroptosis may facilitate persistence of the HIV latent reservoir by promoting homeostatic proliferation of memory CD4+ cells. These results improve our understanding of the long-term T cell dynamics in HIV-1 infection, and support that new treatment strategies, such as the use of caspase-1 inhibitors that inhibit pyroptosis, may maintain the CD4+ T cell population and reduce the latent reservoir size.

Citing Articles

Modelling HIV-1 control and remission.

Vemparala B, Chowdhury S, Guedj J, Dixit N NPJ Syst Biol Appl. 2024; 10(1):84.

PMID: 39117718 PMC: 11310323. DOI: 10.1038/s41540-024-00407-8.


Role of apoptotic protease activating factor-1 in CD4+ depletion during HIV progression.

Garuba W, Adedeji A, Adedokun K, Ayelagbe O, Abdullahi I, Munirudeen I Int J Health Sci (Qassim). 2024; 18(3):30-38.

PMID: 38721142 PMC: 11075444.


Role of pyroptosis in the pathogenesis of various neurological diseases.

Oladapo A, Jackson T, Menolascino J, Periyasamy P Brain Behav Immun. 2024; 117:428-446.

PMID: 38336022 PMC: 10911058. DOI: 10.1016/j.bbi.2024.02.001.


Mitochondrial disturbance related to increased caspase-1 of CD4T cells in HIV-1 infection.

Yu F, Ma C, Jin X, Zhao H, Xiao J, Li L BMC Infect Dis. 2024; 24(1):129.

PMID: 38267841 PMC: 10809604. DOI: 10.1186/s12879-023-08485-5.


Co-infection of Hepatitis B and Hepatitis C among HIV-infected patients: A cross-sectional study from tertiary care hospital of eastern Nepal.

Shrestha L, Yadav G, Pradhan S, Sharma A, Pandit T, Chhetry R PLoS One. 2022; 17(3):e0264791.

PMID: 35239716 PMC: 8893711. DOI: 10.1371/journal.pone.0264791.


References
1.
Boxer M, Quinn A, Shen M, Jadhav A, Leister W, Simeonov A . A highly potent and selective caspase 1 inhibitor that utilizes a key 3-cyanopropanoic acid moiety. ChemMedChem. 2010; 5(5):730-8. PMC: 3062473. DOI: 10.1002/cmdc.200900531. View

2.
Chan M, Petravic J, Ortiz A, Engram J, Paiardini M, Cromer D . Limited CD4+ T cell proliferation leads to preservation of CD4+ T cell counts in SIV-infected sooty mangabeys. Proc Biol Sci. 2010; 277(1701):3773-81. PMC: 2992704. DOI: 10.1098/rspb.2010.0972. View

3.
Doitsh G, Cavrois M, Lassen K, Zepeda O, Yang Z, Santiago M . Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue. Cell. 2010; 143(5):789-801. PMC: 3026834. DOI: 10.1016/j.cell.2010.11.001. View

4.
Maroso M, Balosso S, Ravizza T, Iori V, Wright C, French J . Interleukin-1β biosynthesis inhibition reduces acute seizures and drug resistant chronic epileptic activity in mice. Neurotherapeutics. 2011; 8(2):304-15. PMC: 3101825. DOI: 10.1007/s13311-011-0039-z. View

5.
Mills E, Bakanda C, Birungi J, Chan K, Ford N, Cooper C . Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda. Ann Intern Med. 2011; 155(4):209-16. DOI: 10.7326/0003-4819-155-4-201108160-00358. View